AMAG Pharmaceuticals to buy biopharmaceutical firm Perosphere
The deal will allow AMAG to acquire global rights of ciraparantag, a next generation anticoagulant reversal agent, from Perosphere. As per terms of the deal, Perosphere equityholders will